Sanders-Brown Center on Aging - the Mind Matters podcasts

Dr. Lance Johnson discusses APOE and the link to brain metabolism

21 min · 21. april 2022
Forsidebilde av episoden Dr. Lance Johnson discusses APOE and the link to brain metabolism

Beskrivelse

From the lab website of Dr. Lance Johnson: “Research in our lab is dedicated to understanding the role of the Alzheimer's disease risk factor Apolipoprotein E (APOE) in cerebral metabolism. With a special focus on glia and their contributions to neurodegeneration, we employ a variety of transcriptomic and metabolomic approaches (from cells to mice to humans) in order to identify early-life changes in metabolism associated with APOE. Our lab's overarching goal is to discover new therapeutic targets that will allow us to reprogram metabolism in individuals at-risk for Alzheimer's Disease in order to enhance cognitive resilience and to extend the brain’s health span.” For further information, please see http://www.ljohnsonlab.com

Kommentarer

0

Vær den første til å kommentere

Registrer deg nå og bli medlem av Sanders-Brown Center on Aging - the Mind Matters podcasts sitt community!

Prøv gratis

Prøv gratis i 14 dager

99 kr / Måned etter prøveperioden. · Avslutt når som helst

  • Eksklusive podkaster
  • 20 timer lydbøker i måneden
  • Gratis podkaster

Alle episoder

11 Episoder

Forsidebilde av episoden Dr. Lance Johnson discusses APOE and the link to brain metabolism

Dr. Lance Johnson discusses APOE and the link to brain metabolism

From the lab website of Dr. Lance Johnson: “Research in our lab is dedicated to understanding the role of the Alzheimer's disease risk factor Apolipoprotein E (APOE) in cerebral metabolism. With a special focus on glia and their contributions to neurodegeneration, we employ a variety of transcriptomic and metabolomic approaches (from cells to mice to humans) in order to identify early-life changes in metabolism associated with APOE. Our lab's overarching goal is to discover new therapeutic targets that will allow us to reprogram metabolism in individuals at-risk for Alzheimer's Disease in order to enhance cognitive resilience and to extend the brain’s health span.” For further information, please see http://www.ljohnsonlab.com

21. april 202221 min